CBC Health – Overview
For more than twenty years, our founding company, Cord Blood Center Group (CBCG) has recorded many firsts in regenerative health. In 1997, CBCG was among the first in Europe to process and prepare cord blood for regenerative transplants. CBCG was one of the first companies in Europe to collect, process and store cord blood, cord tissue and placenta tissue with over 160,000 clients. These individuals may benefit from the regenerative effect of their cord blood in the future. Eurocord-Slovakia, a CBCG company, was among the first in Europe to establish a registry and repository for storing personal cord blood and a repository for donated cord blood which can be used for regenerative treatments for the general population.
CBC Health will always be at the forefront of regenerative health science, as CBCG is directly involved in pushing the envelope for regenerative health by supporting regenerative clinical research. Since 2012, CBCG has conducted or participated in research projects and clinical trials aimed to help people find therapies for diseases that have no cure today, like the treatment of cerebral palsy and ischemic stroke. CBCG has also participated in clinical studies at leading medical institutions like Duke University Hospital, USA.
In 2018, CBC Health began the process to open a new medical facility in Munich, Germany, known as CBCHealth Med Munich, which will focus on providing cord blood treatments for patients suffering from Ischemic Stroke. If you are interested in learning more about the Munich location, please click here to visit, CBCHealth Med Munich.
CBC Health Benefits From CBCG’s Processing Excellence
Eurocord-Slovakia was named the best in the world for the highest average quantity of total nucleated cells in its cord blood grafts eight years in a row (BMDW, Annual Reports 2007- 2014). CBCG’s process preserves the highest possible quantity and broadest spectrum of stem cells.
CBC Health Benefits From CBCG’s Knowledge Base
CBCG is leading the way as a regenerative health company with a solid foundation of licensed laboratories and storage facilities. The company has active branches in Switzerland, Austria, Slovakia, Italy, Romania, Hungary, Czech Republic and is expanding into new markets. Eurocord-Slovakia is a member of the international bone marrow and cord blood donors database; it is connected to the EMDIS, the international exchange network; and it is an associate member of other prestigious international organizations that set quality standards for cord blood products such as The World Marrow Donor Association (WMDA).